Skip to main content
. 2021 Nov 25;12:6855. doi: 10.1038/s41467-021-27180-0

Fig. 6. T403R RaTG13 S is sensitive to EK-1 and sera from vaccinated individuals but not Casivirimab.

Fig. 6

a−c Automated quantification of GFP fluorescence of Caco-2 cells infected with VSVΔG-GFP pseudotyped with indicated S variants. The virus was pre-treated (30 min) with the indicated amounts of a EK-1 b Casirivimab (orange), and c Sera of BNT162b2 vaccinated patients. Lines represent the mean of three independent experiments (±SEM). d Sera of AZ/BNT162b2 and 2xBNT162b2 vaccinated patients with VSVΔG-GFP pseudotyped with RaTG13 S. Lines represent the mean of three biological replicates. Mean of the inhibition of VSVΔG-GFP pseudotyped with e RaTG13 S by Sera of AZ/BNT162b2 or 2x BNT162b2 vaccinated patients and f RaTG13 S or SCoV-2 by the Sera of AZ/BNT162b2 (left) or 2x BNT162b2 (right) vaccinated patients Lines represent the mean of three independent experiments (±SEM).